Monthly Archives: September 2015

Securities Class Action Lawsuit Against ConforMis, Inc.

Gilman Law LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts against ConforMIS, Inc. (“ConforMIS” or the “Company”)(CFMS) and certain of its officers for alleged violations of the federal securities laws under the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint was brought on behalf of a class of shareholders who purchased ConforMIS common stock pursuant to the Company’s Registration Statement and Prospectus issued in connection with the Company’s initial public offering (“IPO”) on or about July 1, 2015, or on the open market between July 1, 2015 and August 28, 2015, and alleges that the Defendants made false and/or misleading statements, and failed to disclose material adverse facts regarding the Company’s business, operational and compliance policies in connection with the IPO and in filings with the SEC. Specifically, the Complaint asserts that the Defendants violated the Securities Act and the Exchange Act by making false and/or misleading statements and/or failing to disclose that: (i) the Company’s manufacturing processes were flawed; (ii) as a result of the flaws in the Company’s manufacturing process, a number of the Company’s knee replacement product systems were defective; and (iii) as a result of the foregoing, ConforMIS’ public statements were materially false and misleading.

ConforMIS, headquartered in Bedford, Massachusetts, is a medical technology company that develops, manufactures, and sells customized joint replacement implants.

If you are an investor who purchased ConforMIS common stock pursuant to or in connection with the IPO or thereafter until August 28, 2015, and suffered a loss then please contact Gilman Law LLP today, at 1-888-252-0048 or www.investment-losses.com, to ensure your legal rights are not forfeited.

About Gilman Law LLP

Gilman Law LLP, a leading financial law firm, has been recognized for delivering successful results to their clients across a broad range of claims stemming from securities class actions and derivative actions. For over 35 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.

Contact: Kenneth G. Gilman

1-888-252-0048

Posted in Current Lawsuits & Investigations, General Legal News | Leave a comment

RECEPTOS INC. SHAREHOLDER LAWSUIT: BREACH OF FIDUCIARY DUTY IN PROPOSED BUYOUT BY CELGENE CORPORATION

Receptos, Inc. and Celgene, Corp. Lawsuit Details – Celgene Corporation’s Proposed Buyout

Gilman Law LLP announced that a complaint on was filed on July 20, 2015 on behalf of a shareholder of Receptos, Inc. (NASDAQ: RCPT) seeking to block Celgene’s proposed $7.2 billion buyout and for breach of fiduciary duty by accepting an offer that undervalued the company’s stock when the company was about to have tremendous growth.

Receptos Lawsuit

Receptos Lawsuit

The complaint explains, under the proposed buyout, Receptos agreed not to continue discussion with other potential buyers and give Celgene four business days to match a competing proposal. Receptos also agreed to pay Celgene a $230 million termination fee if the company sold to a higher bidder. The plaintiff states these points made it nearly impossible for Receptos to shop for possible higher bidders. The complaint went on to explain that the Receptos’ drug, Ozanimod-used to treat relapsing multiple sclerosis and irritable bowel disorder, is in late-stage trials which analyst estimate could be worth $5 billion. Considering this, Wedbush Securities raised its target price for Receptos stock from $211 to $348 in June, 2015. Under the proposed buyout, Celgene is offering $232 per share. The complaint alleges the shareholders will not be given a fair portion of Receptos’ assets.

We are encouraging shareholders who invested in Receptos Inc. and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

Posted in Current Lawsuits & Investigations, General Legal News | Leave a comment

LRR ENERGY LP SHAREHOLDERS LAWSUIT: BREACH OF FIDUCIARY DUTY IN MERGER WITH VANGUARD NATURAL RESOURCES LLC

LRR Energy LP Lawsuit Details – Vanguard Natural Resources LLC Merger

Gilman Law LLP announced that a complaint on was filed on July 10, 2015 on behalf of shareholders of LRR Energy LP (NASDAQ: LRE) for possible breaches of fiduciary duty in connection with its acquisition by Vanguard Natural Resources.

LRR Energy Lawsuit

Receptos Lawsuit

The complaint claims the offer to acquire LRR Energy for $251 million in Vanguard common units is inadequate and does not take into consideration LRR Energy’s current performance and probable growth. The complaint also contends that the Board eliminated negotiations with other potential bidders when it agreed to a “no shop” provision which included a $7.3 million termination fee. The complaint further alleges LRR Energy’s SEC registration statement was inaccurate and that the company agreed to acquire Eagle Rock Energy Partners LLP for $614 million, causing the shareholders to have a smaller percentage of ownership in Vanguard.

We are encouraging shareholders who invested in LRR Energy LP and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

Posted in Current Lawsuits & Investigations, General Legal News | Leave a comment

BROADCOM CORPORATION SHAREHOLDERS LAWSUIT: BREACH OF FIDUCIARY DUTY IN MERGER WITH AVAGO TECHNOLOGIES LTD.

Broadcom Corporation Lawsuit Details – Avago Technologies Ltd. Merger

Gilman Law LLP announced that a complaint on was filed on June 18, 2015 on behalf of shareholders of Broadcom Corporation (NASDAQ: BRCM) for possible breaches of fiduciary duty in connection with its merger its rival Avago Technologies Ltd. The complaint claims the proposed merger and offer to acquire Broadcom for $37 billion is inadequate and will leave the common stockholders “shortchanged”. The complaint also alleges those in control of the company stand to benefit the most and the cash-and-stock deal only offers a 16% premium to Broadcom’s closing price.

Broadcom Lawsuit

Broadcom Lawsuit

We are encouraging shareholders who invested in Broadcom Corporation and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

Posted in Current Lawsuits & Investigations, General Legal News | Leave a comment

iGATE CORPORATION SHAREHOLDERS LAWSUIT: BREACH OF FIDUCIARY DUTY IN MERGER WITH CAP GEMINI SA

iGate Corporation Lawsuit Details – iGate Corporation Merger

Gilman Law LLP announced that a complaint was filed on behalf of shareholders of iGate Corporation (NASDAQ: IGTE) for possible breaches of fiduciary duty in connection with its merger with the French consulting firm Cap Gemini SA. Under the terms of the proposed merger, a termination fee of $161 million was agreed upon, making it almost impossible for the iGate’s investors to obtain a better offer for their shares. The complaint alleges that the extremely high termination fee deterred potential bidders from making a higher offer. If a better deal was found, the company and its shareholders would suffer a $161 million loss.

We are encouraging shareholders who invested in iGate Corporation and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

Posted in Current Lawsuits & Investigations, General Legal News | Tagged | Leave a comment

HUMANA INC. SHAREHOLDERS LAWSUIT: BREACH OF FIDUCIARY DUTY IN AETNA INC. PROPOSED ACQUISTION

Humana Inc. Lawsuit Details – Proposed Acquisition by Aetna Inc.

Gilman Law LLP announced that a complaint on was filed on July 22, 2015 on behalf of shareholders of Humana Inc. (NASDAQ: HUM) to stop the proposed $37 billion acquisition of Humana by Aetna Inc. stating the proposed deal undervalues Humana and underestimates the antitrust issues to come. Plaintiff claims Humana and its board of directors breached their fiduciary duty to shareholders by agreeing to be purchased by Aetna for 0.8375 shares of common stock of Aetna and $125 in cash without interest for each Humana share. Based on this, the plaintiff believes Human shareholders will not receive the full benefits of their investment if this acquisition goes through. The complaint also states that Humana locked the deal with “no solicitation” provisions as well as a merger agreement that grants Aetna access to any rival bidder’s information and allows Aetna to top any superior offer by just matching it. These provisions could deter other entities from making a better bid for Humana.

Humana Lawsuit

Humana Lawsuit

We are encouraging shareholders who invested in Humana Inc. and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

Posted in Current Lawsuits & Investigations, General Legal News | Tagged | Leave a comment

MYLAN NV SHAREHOLDER LAWSUIT: BREACH OF FIDUCIARY DUTY

Mylan NV Lawsuit Details – Concealment of Tax Inversion and Use of Unlawful Call Option

Gilman Law LLP announced that a complaint on was filed on July 21, 2015 on behalf of a shareholder of Mylan NV (NASDAQ: MYL) claiming the company and its leaders hid the circumstances of a tax inversion and created an unlawful call option to block a potential acquisition by Teva Pharmaceutical Industries, Inc. The complaint alleges that Mylan’s board of directors convinced shareholders to approve a tax inversion that converted the old Mylan Inc. to the new Mylan NV, a company that would be traded on NASDAQ and follow its listing rules. The complaint continues to state that Mylan’s board then issued a call option in April to a specifically created Dutch foundation, Stichting Preferred Shares Mylan. The call option would allow Stichting to buy enough shares to control Mylan’s voting stock and eliminate the shareholder’s voting power. The complaint states this call option was planned to prevent Mylan shareholders from accepting Teva’s acquisition offer, which would have given the shareholders a 48.3% premium.

Mylan Lawsuit

Mylan Lawsuit

We are encouraging shareholders who invested in Mylan NV and currently hold any of those shares to contact our office for a free consultation by submitting our free consultation form online or calling our office toll free at (888)-252-0048.

WHAT YOU CAN DO TO RECOVER YOUR LOSSES?

About the Shareholder Rights Law Firm of Gilman Law LLP

The attorneys at Gilman Law have over 35 years of experience in securities class action law suits and have been involved in all major aspects of securities litigation. Our experienced securities attorneys focus on cases involving stock manipulation, securities fraud, investment fraud, shareholder rights violations, and securities arbitration.

Posted in Current Lawsuits & Investigations, General Legal News | Tagged | Leave a comment

Awards & Recognition

The Securities and Investment Fraud Attorneys at Gilman Law LLP have been recognized by numerous leading legal publications:

Investment Losses Law Firm